What to do with refractory urticaria patients

Current Allergy and Asthma Reports

Volumn 11, Issue 3, 2011, Pages 189-191

  Kaplan, Allen P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; CYCLOSPORIN; DIPHENHYDRAMINE; HYDROXYZINE; LORATADINE; OMALIZUMAB; PLACEBO;

CHRONIC URTICARIA; COLD URTICARIA; DERMOGRAPHISM; DRUG EFFICACY; DRUG RESPONSE; HUMAN; NOTE; PATIENT CARE; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; URTICARIA;

HUMANS; URTICARIA;

EID: 79955879189     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-011-0187-6     Document Type: Note

References (28)

1. Kaplan A. What the first 10,000 patients with chronic urticaria have taughtme: a personal journey. J Allergy Clin Immunol. 2009;123:713-7.
2. Weiler J, Bloomfield J, Woodworth G, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Int Med. 2000;132:354-63.
3. Verster J, Volkerts E, van Oosterwijck A, et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol. 2003;111:623-7. (Pubitemid 36337888)
4. Ramaekers J, O'Hanlon J. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. European J Clin Pharm. 1994;47:261-6. (Pubitemid 24330668)
5. Church M, Maurer M, Simons F, et al. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy. 2010;65:459-66.
6. Bender B, Berning S, Dudden R, et al. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. J Allergy Clin Immunol. 2003;111:770-6. (Pubitemid 36470247)
7. Kaplan A. Chronic urticaria and angioedema. N Engl J Med. 2002;346:175-9. (Pubitemid 34438884)
8. Boyce J. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117:1415-8. (Pubitemid 43795744)
9. Houser D, Arbesman C, Ito K, et al. Cold urticaria. Immunologic studies. Am J Med. 1970;49:23-33.
10. Kaplan A, Garofalo J, Sigler R, et al. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med. 1981;305:1074-7. (Pubitemid 12234832)
11. Newcomb R, Nelson H. Dermographia mediated by immunoglobulin E. Am J Med. 1973;54:174-80.
12. Botto N, Warshaw E. Solar urticaria. J Am Acad Dermatol. 2008;59:909-20.
13. Guzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63:1563-5.
14. Waibel K, Reese D, Hamilton R, et al. Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol. 2009;125:490-1.
15. Estes S, Yung C. Delayed pressure urticaria: an investigation of some parameters of lesion induction. J Am Acad Dermatol. 1981;5:25-31. (Pubitemid 11003409)
16. Barlow R, Ross E, MacDonald D, et al. Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria. Br J Dermatol. 1994;131:341-7. (Pubitemid 24290217)
17. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2) LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427-43.
18. Hide M, Francis D, Grattan C, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328:1599-604. (Pubitemid 23151920)
19. Kikuchi Y, Kaplan A. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol. 2001;107:1056-62. (Pubitemid 32523348)
20. Leznoff A, Sussman G. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol. 1989;84:66-71. (Pubitemid 19188993)
21. Kikuchi Y, Fann T, Kaplan A. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol. 2003;112:218. (Pubitemid 36819836)
22. Staevska M, Popov T, Kralimarkova T, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol. 2010;125:676-82.
23. Grattan C, O'Donnell B, Francis D, et al. Randomized doubleblind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol. 2000;143:365-72.
24. Kessel A, Toubi E. Cyclosporine A in severe chronic urticaria: the option for long-term therapy. Allergy. 2010;65:1478-82.
25. Kaplan A, Joseph K, Maykut R, et al. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008;122:569-73.
26. Spector S, Tan R. Effect of omalizumab on patients with chronic urticaria. Annals Allergy Asthma Immunol. 2007;99:190-3. (Pubitemid 47264781)
27. Dreyfus D. Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema. Annals Allergy Asthma Immunol. 2008;100:624-5. (Pubitemid 351829870)
28. Ferrer M, Gamboa P, Sanz M, et al. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol 2011 (in press).